Aim: Cardiovascular disease is a major cause of mortality in dialysis patients. Epicardial adipose tissue (EAT) has been proposed as a cardiovascular risk marker in this population. Subclinical hypothyroidism and low free triiodothyronine (fT3) levels are associated with EAT in patients without chronic renal failure. The aim of this study was to investigate the relationship between EAT and low free T3 levels in peritoneal dialysis (PD) patients. Methods: A total of 125 prevalent PD patients were enrolled in this cross-sectional study. The epicardial fat thickness (EFT) was measured by echocardiography, and the endothelial function was assessed by flow mediated dilatation (FMD). Thyroid function tests were performed by an enzyme immunoassay. Results: The mean age of the patients was 51±13, and the time on PD was 36 months. The mean EFT was 6.7±2.9 mm. The EFT correlated positively with the patient age, systolic blood pressure (BP), mean BP, high sensitivity C-reactive protein (hs-CRP) level and body mass index (BMI), and negatively with the fT3 level and FMD. The median fT3 value was 2.53, and patients were divided according to their serum fT3 values (within the normal range and below the reference level). Compared with patients in the low fT3 group, the subjects in the normal fT3 group had higher serum albumin levels and FMD, but a lower BMI, plasma fasting glucose level, EFT, TSH level, hs-CRP level, low density lipoprotein (LDL) cholesterol level and mean BP in office measurements, and both the diastolic BP and mean BP by ambulatory blood pressure measurement. A multivariate linear regression analysis showed that the EFT was predicted by the hs-CRP and fT3 levels. Conclusion: Low free T3 levels are associated with the epicardial fat thickness in PD patients. Further studies are needed to evaluate the pathogenesis and to support these findings.
Introduction
Cardiovascular (CV) disease is a major cause of morbidity and mortality in patients with end-stage renal disease (ESRD). In fact, more than 50% of the deaths among peritoneal dialysis (PD) patients can be attributed to CV disease 1) . In addition to traditional risk factors, the presence of uremic toxins, anemia, vascular calcification, endothelial dysfunction, oxidative stress and hypervolemia accelerate the development of CV in these patients 2) .
Obesity has long been linked to the development of cardiovascular disease, especially to deaths from coronary artery disease, and increasing numbers of studies have confirmed the importance of the relationship 3, 4) . Obesity is associated with an increase in the included in this study were selected from this group on the basis of the following inclusion and exclusion criteria: The inclusion criteria in our study were echocardiogram, FMD and EAT data measured within a period of six months and a blood sample obtained for measurement of the thyroid and gonadal hormones within the same interval. The exclusion criteria were abnormal TSH levels, the use of anti-thyroid medications and cardiovascular issues. In total, 43 patients were excluded because of (Ⅰ) abnormal TSH levels and/or the use of anti-thyroid medications (n = 17), (Ⅱ) the presence of cardiac arrhythmia (atrial fibrillation, a history of supraventricular and ventricular tachycardia attack, cardiac dysrhythmia related to pacemaker use) (n = 6) and (Ⅲ) major cardiovascular diseases (history of coronary artery bypass surgery, cardiomyopathy, history of acute coronary syndrome in last six months) as assessed by the medical history and transthoracic echocardiography (n = 20). In addition, 26 patients who were eligible for the study protocol refused to participate in the study and did not provide informed consent. Finally, this study was conducted in the remaining 125 patients. Twenty-eight percent of the enrolled patients were diabetic. In the study population, 40% and 18% of the patients were receiving treatment with anti-hypertensive agents and statins, respectively. The peritoneal dialysis patients were dialyzed using the Baxter Twin Bag (Baxter Healthcare SA, Castlebar, County Mayo, Ireland) and Fresenius A.N.D.Y Plus or Stay-safe systems (Fresenius Medical Care GmbH, Hamburg, Germany).
Biochemical Measurements
Blood samples were taken from the vein of the antecubital fossa, with subjects in a seated position and following a 20 min rest following 12 hours of fasting. The glucose, creatinine and lipid profiles were determined using standard methods. The C-reactive protein (CRP) level was measured using a BN2 model nephelometer (Dade-Behring, Germany). Tri-potassium EDTA based anticoagulated blood samples were drawn to determine the complete blood cells counts (Sysmex K-1000 auto analyzer, Block Scientific, USA) within 30 min of sampling.
The serum prolactin levels were quantified using the Siemens Advia Centaur XP Immunoassay System. Prolactin was measured with an Advia Centaur PRL Immunoassay Kit from Bayswater (Victoria, Australia). The lower limit of detection for prolactin was 3.3 ng/mL. The serum total testosterone levels were quantified by a Immulite 2000 XP Immunoassay System using an Immulite 2000/System 2000 TES Kit from Lianberis (Gwynedd, U.K.). The lower limit of detec-visceral and epicardial adipose tissue (EAT) volume. EAT is visceral adipose tissue which is located subepicardially around the heart. Although little is known about the physiological and metabolic roles of EAT, it has been implicated as a CV risk factor in non-uremic and uremic patients 5, 6) . Recently, Turkmen et al. reported higher EAT in dialysis patients compared to healthy controls, and a significant association of EAT with malnutrition-inflammation-atherosclerosis-calcification (MIAC) syndrome 7) . Additionally, it was shown that EAT was correlated with atherosclerosis, arterial stiffness and the presence of coronary calcification in long-term hemodialysis (HD) patients 8) .
Thyroid hormone abnormalities are common in ESRD patients 9) . Recent advances in our understanding of the thyroid system have strongly implicated both subclinical hypothyroidism and low free triiodothyronine (fT3) levels in the cardiac and atherosclerotic abnormalities observed in non-renal patients 10) . On the other hand, Tatar et al. recently demonstrated that low fT3 levels are associated with carotid atherosclerosis in HD patients 11, 12) . Yilmaz et al. demonstrated a relationship between low fT3 levels and endothelial dysfunction in patients suffering from renal failure 13) . Moreover, there is a well-accepted association between low fT3 levels and mortality in patients suffering from renal failure 14) . EAT and low free T3 levels are separate risk factors for CV diseases in patients suffering from renal failure, and Moon et al. showed that low levels of fT3 and fT4 were significantly associated with an increased pericardial fat volume in patients without chronic renal failure 15) . However, to the best of our knowledge, the association between EAT and low fT3 levels is unclear.
The aim of this study was to investigate the relationships among the fT3 level, endothelial dysfunction and EAT in PD patients.
Methods

Study Population
This single-center, cross-sectional study was performed on monitored patients undergoing PD at the Nephrology Department of the Medical Faculty of Erciyes University, Turkey, for a period of six months between March 2013 and September 2013. The study was approved by the University Ethics Committee. All participants provided written informed consent, and the study was performed in accordance with the Declaration of Helsinki.
In our center, the majority (~90%) of dialysis patients are on PD. One hundred and ninety-four PD patients are currently being followed. The patients probe. The subjects remained at rest in the supine position for at least 15 min before the examination started. Each subject's right arm was comfortably immobilized in the extended position to allow for consistent recording of the brachial artery 2-4 cm above the antecubital fossa. Three adjacent measurements of end-diastolic brachial artery diameter were made from single 2D frames. All ultrasound images were recorded on a Super Video Home System (SVHS) videotape for the subsequent blinded analysis. The maximum flow-mediated vasodilation (FMD) diameters were calculated as the average of the three consecutive maximum diameter measurements after hyperemia and nitroglycerin, respectively. The FMD was then calculated as the percentage change in the diameter compared with the baseline resting diameters.
Ambulatory Blood Pressure Measurements
24-hour blood pressure monitoring was performed using a Del Mar Medical Ressurometer Model P6 (Del Mar Reynolds, Irvine, CA, USA), and the results were assessed using the manufacturer's computer software program. Ambulatory measurements were conducted once every 15 minutes from 7 AM until 11 PM, and then once every 30 minutes from 11 PM until 7 AM.
The evaluation was performed by taking the mean values of the day and night blood pressures into account. Hypertension was considered to be present if the average systolic pressure was ≥ 130 mm Hg and/or the average diastolic pressure was ≥ 80 mmHg for the whole day, or if the individual was taking antihypertensive medication.
Statistical Analysis
Continuous variables were tested for normal distribution by the Kolmogorov-Smirnov test. For continuous variables, the results are presented as the mean values±SD for parametric variables (normal data distribution) or as medians (minimum, maximum) for non-parametric variables (those without a normal data distribution). The differences between the two groups were evaluated with Student's t -test (normal distribution) or the Mann-Whitney U -test (those without a normal distribution). Pearson correlation coefficients were calculated to examine the degree of association between the variables. A p value ＜0.05 was considered to be significant. Variables for which the unadjusted univariate p value was ＜0.10 in the linear regression analysis were included in the multivariate analysis. Variables were considered to be significant at p＜0.10 in the univariate analysis, and were included in the tion for total testosterone was 0 ng/mL. The serum progesterone and estradiol (E2) levels were quantified by a Siemens Advia Centaur XP Immunoassay System. Progesterone was measured with an Advia Centaur PRGE Immunoassay Kit from Bayswater (Victoria, Australia). The lower limit of detection for progesterone was 0.21 ng/mL. E2 was measured with an Advia Centaur CP E2 Immunoassay Kit from Bayswater (Victoria, Australia). The lower limit of detection for E2 was 18.9 ng/mL.
The serum TSH, free T4 (fT4) and free T3 (fT3) levels were quantified by the Siemens Advia Centaur XP Immunoassay System using the Advia Centaur FT3-FT4-TSH3UL Kit from Bayswater (Victoria, Australia). The reference values were: 0.57-5.6 mIU/L for TSH, 0.88-1.72 ng/dL for fT4 and 3.54-6.82 pg/ mL for fT3.
Echocardiography and Epicardial Adipose Tissue Measurement
All participants underwent transthoracic echocardiography imaging using an echocardiograph equipped with a broadband transducer (Vivid S6, GE Medical Systems, USA). Measurements were obtained from the long axis and apical four-chamber view according to the standard criteria. The echocardiographic images were entered into a computerized database (EchoPac system). The offline measurements of the EAT were performed by two cardiologists blinded to the subjects' information in order to avoid interreader variability. The echocardiograms of 20 patients were randomly selected, and a second measurement of the EAT was performed two weeks later in order to assess the inter-observer and intra-observer variability. Echocardiographic assessments of the EAT were performed according to the method described previously by Iacobellis et al. 16) . The epicardial fat was identified as an echo-free space in the pericardial layer by twodimensional echocardiography 17, 18) . The maximum EAT was measured at the point on the free wall of the right ventricle along the midline of the ultrasound beam, perpendicular to the aortic annulus, as the anatomical landmark at end-diastole in three cardiac cycles. The inter-observer and intra-observer variabilities of the EAT were found to be 3.5% and 2.9%, respectively.
Endothelial Function Test
Endothelial dysfunction was assessed according to the method described by Celermajer et al. 19) . Measurements were made by a single observer using an ATL 5000 ultrasound system (Advanced Technology Laboratories Inc., Bothell, WA, USA) with a 12-Mhz considered to be significant, and the confidence interval (CI) was set at 95%. All statistical analyses were performed using the SPSS version 15 software pro-model. We reduced the model by using backwards elimination at a p＜0.10 stringency level in the multivariate linear regression analysis. A p value ＜0.05 was ＊ p = chi square value ¥ p = non-parametric analysis the fT3, age, FMD, hs-CRP level, BMI, systolic BP and mean BP levels, but not with the duration of dialysis, cholesterol, diastolic BP, triglycerides or albumin level. Meanwhile, the fT3 correlated with EFT, age, duration of dialysis, FMD, hs-CRP level, albumin level, BMI and the blood pressure measured by ABPM and the mean BP of office measurements, but not with the cholesterol levels, triglycerides or systolic and diastolic BP of the office measurements. EAT inversely correlated with the FMD (r =−0.37, p＜0.001) and fT3 level (r =−0.26, p = 0.004; (Fig. 1) 
Multivariate Regression Analysis
As shown in Table 3 , we constructed a multivariate regression analysis model to assess the relative independence of the observed correlations. The model was adjusted for age, the hs-CRP level, mean ABPM, BMI and fT3 level. We used a multivariate linear regression analysis with backward elimination, and compared the retained predictors using likelihood ratio tests. EFT was predicted by the hs-CRP level (β= 0.17, p = 0.03) and fT3 level (β=−0.25, p = 0.02). gram (SPSS, Inc., Chicago, IL, USA).
Results
Characteristics of the Patients with High or Low Serum fT3 Levels
The demographic, clinical and laboratory characteristics of the study population are shown in Table 1 . Patients were divided according to the serum fT3 values (within the normal range and below the reference level). Compared with the patients in the low fT3 group, those in the normal fT3 group had higher serum albumin levels (p＜0.001), FMD (＜0.001) and a lower BMI (p = 0.035), lower plasma fasting glucose level (p = 0.041), EFT (p = 0.001), TSH (p＜ 0,001), hs-CRP (p = 0.038), LDL cholesterol (p = 0.047), mean BP in the office measurements (p = 0.017) and both the diastolic BP (p = 0.004) and mean BP (p = 0.002) in the ABPM measurements. All other parameters were similar between the groups.
Univariate Correlations with the EFT
The univariate correlations with EFT are shown in Table 2 . In the whole cohort, EFT correlated with level is associated with EAT in the PD population, and could be a predictive factor for the cardiovascular outcomes. Epicardial adipose tissue is a visceral adipose fat depot that is located subepicardially around both ventricles of the heart, with variable extent and distribution patterns 21) . EAT is metabolically active and acts as a secretory tissue. Several bioactive inflammatory adipokines and cytokines, such as adiponectin, TNFalpha, IL-1, IL-6 and resistin are released from EAT 22) . These molecules have been proposed to be responsible for the cardiac effects of EAT 23) . Epicardial adipose tissue can be calculated using several methods, including computed tomography (CT), magnetic resonance
Discussion
Epicardial adipose tissue is associated with cardiovascular events in ESRD patients. Although the association between low fT3 levels and EAT in patients without renal failure has been well established, the relationship between low fT3 levels and EAT in peritoneal dialysis patients has been unclear. In addition, tEAT has recently been shown to be a predictor of mortality in hemodialysis patients 20) . To the best of our knowledge, ours is the first study to investigate the association between the fT3 levels and EAT in a population of patients being treated with peritoneal dialysis. Our findings suggest that the fT3 The original models included the age, hs-CRP, fT3, BMI and mean BP (ambulatory). hs-CRP, high sensitivity C-reactive protein; ABPM, ambulatory blood pressure measurement; EFT, epicardial fat thickness Adjusted r 2 = 0.31 for the EAT Bold values are significant of thyroid hormones in ESRD patients. Some changes have been reported in the hypothalamus-hypophysisthyroid axis and peripheral thyroid hormone metabolism, and dysfunctional thyroid hormone metabolism becomes more prevalent with the progression of chronic kidney disease, ranging from 5% to 25% as the stage of kidney disease worsens 31) . The prevalence of low fT3 levels in ESRD patients was reported to be approximately 20-25% 31) . Consistent with the literature, this ratio was found to be 25% in our study. Tatar et al. revealed that low fT3 levels are associated with increased carotid atherosclerosis and arterial stiffness 11) . T3 is a potent stimulus for NO-dependent vasodilatation in the forearm in healthy subjects. It has also been shown that there is an association between low fT3 levels and endothelial dysfunction in stage 3-4 chronic kidney disease patients 13) . We also observed a significant relationship between the fT3 levels and FMD in our study; which supports that fT3 affects the endothelial function. Hypertension, hyperlipidemia, hypercoagulability, hyperhomocysteinemia and inflammation could all be responsible for the endothelial dysfunction in patients with thyroid dysfunction 12) . Moreover, a low fT3 level has been shown to be associated with inflammation and cardiovascular disease 32) . Carrero et al. reported that low fT3 levels were inversely correlated with markers of inflammation, including IL-6 and CRP 33) . Recently, Zoccali et al. suggested that low fT3 levels may be considered as an independent predictor of mortality in ESRD patients 34) . On the other hand, Ozen et al. showed that the serum fT3 level is a strong and inverse mortality predictor, which is partly explained by its underlying association with malnutrition and inflammation 14) . We also observed a significantly negative association between low fT3 levels and the CRP levels in our study.
There is some evidence that epicardial fat tissue is an active endocrine organ. Studies have revealed that EAT is a source of several proinflammatory and proatherogenic cytokines [21] [22] [23] . We also found a significant association between an inflammatory marker, hs-CRP, and EAT. Inflammation, which is common in ESRD patients, may be the reason for the increased hs-CRP levels. Moreover, it is not clear whether EAT or ESRD is the origin of the inflammation, or whether both make contributions. Further studies are needed to clarify the potential mechanism(s) underlying the development of inflammation.
The relationship between a low fT3 level and EAT remains unclear. Moon et al. found a significant association between low fT3 levels and increased pericardial tissue in a population which consisted of 100 imaging (MRI) or echocardiography. Direct measurement of the epicardial adipose tissue thickness via echocardiography is another reliable method that can be used to measure the visceral adiposity 24) .
Recent interest has shifted towards the association between the EAT and cardiovascular diseases. An increased amount of EAT. as demonstrated by echocardiographic measurements, is associated with carotid atherosclerosis and the arterial stiffness in different populations, such as patients with diabetes mellitus and hypertension 25, 26) . Only a few studies have so far been conducted in patients with renal disease on this issue. Turkmen et al. revealed that the volume of EAT increased in patients with ESRD, and EAT was related to the age, body mass index and malnutrition inflammation atherosclerosis (MIA) syndrome components 7) . In support of this, we also observed that EAT was related to the age, BMI and CRP levels. Turan et al. showed that an increased EAT volume in patients who were treated with hemodialysis for a long time was associated with carotid atherosclerosis, arterial stiffness and coronary calcification. They suggested that the measurement of EAT in these patients can be used as a predictor of vascular injury 8) .
Endothelial dysfunction is an independent predictor of cardiovascular disease. In the literature, some studies have been conducted on the relationships between EAT and endothelial dysfunction in patients with or without renal disease. Sade et al. demonstrated a negative association between EAT and the coronary flow reserve in patients with angiographically normal coronary arteries 27) . Atakan et al. also demonstrated a negative association between the EAT and the coronary flow reserve in 71 patients on chronic hemodialysis 28) . FMD measurement is also a predictor of endothelial dysfunction. In agreement with these previous studies, we also observed a strong, significant, negative association between EAT and FMD in our study, which supports the idea that EAT may be related to endothelial dysfunction.
Several studies have investigated the relationship between EAT and arterial blood pressure, as well as endothelial dysfunction. A strong association between hypertension and an increased amount of EAT has been shown in both echocardiographic and autopsy results 29, 30) . Consistent with the current literature, we also observed a significant relationship among the office arterial blood pressure, ambulatory arterial blood pressure and EAT. Both the office and ambulatory blood pressure monitoring measurements showed that the systolic blood pressure was positively correlated with EAT.
Several changes may be seen in the metabolism euthyroid male patients 15) . However, no previous studies have examined this issue in patients with PD.
Ours is the first study to do so. Low free T3 levels were found to be related to an increased amount of EAT, and the free T3 level was found to be a predictor of EAT according to the results of a multivariate analysis in our study. Moon et al. 15) also found an inverse relationship between the free T3 levels and BMI in their study, and similar results were observed in our study.
There are some limitations associated with our study. First, it is a cross-sectional study. Second, the epicardial adipose tissue thickness was measured via echocardiography instead of computed tomography or MRI. However, echocardiography has several advantages in comparison with CT and MRI, such as the fact that it is more easily accessible, has a low cost and does not require X-ray exposure. EAT obtained by CT or MRI may be more accurate than that obtained by echocardiography, because both CT and MRI use volumetric values, while echocardiography could provide only information about the thickness of EAT. Third, the levels of hormones were studied only one time.
In conclusion, thyroid dysfunction and low fT3 levels are common among patients treated with peritoneal dialysis. Low fT3 levels are associated with the epicardial adipose thickness. Further studies are needed to evaluate the pathogenesis in association with these findings and to support the present findings.
